Craft

Antares Pharma

Stock Price

$5.6

2022-05-24

Market Capitalization

$950.5 M

2022-05-24

Revenue

$184 M

FY, 2021

Antares Pharma Summary

Company Summary

Overview
Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company's injection products include syringes and self-injection systems for patients with rheumatoid arthritis, psoriasis, migraine and cluster headache, needle-free and disposable pressure-assisted auto injectors for various purposes. Antares Pharma has strategic alliances and partnership arrangements with several pharmaceutic companies.
Type
Public
Status
Active
Founded
1979
HQ
Ewing, NJ, US | view all locations
Website
http://www.antarespharma.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Robert F. Apple

    Robert F. Apple, President and Chief Executive Officer

    • Leonard S. Jacob

      Leonard S. Jacob, Chairman of the Board Chairman, Governance & Nominating Committee

      • Anton Gueth, Director

        • Peter S. Greenleaf, Director

          LocationsView all

          3 locations detected

          • Ewing, NJ HQ

            United States

            100 Princeton S # 300

          • Hopkins, MN

            United States

            12500 Whitewater Dr

          • Plymouth, MN

            United States

            3905 Annapolis Ln N #105

          Antares Pharma Financials

          Summary Financials

          Revenue (Q1, 2022)
          $41.6M
          Net income (Q1, 2022)
          ($2.3M)
          Cash (Q1, 2022)
          $61.7M
          EBIT (Q1, 2022)
          ($2.8M)

          Footer menu